OBJECTIVE -Insulin resistance may contribute to cardiovascular disease and the progression of renal insufficiency in patients with chronic kidney disease (CKD). However, feasible methods for estimating insulin sensitivity in large-population CKD studies have not been validated. The purpose of this study was to attempt to validate several commonly used steady-state insulin sensitivity (SI-SS) indices in a CKD population.
C
hronic kidney disease (CKD) affects up to 20 million Americans and has high morbidity and mortality attributed to atherosclerotic cardiovascular disease (CVD) (1-4). Prevention of CVD in this high-risk population depends on accurate identification and aggressive modification of risk factors. Although largescale observational studies have identified CVD risk factors in the general population and provide the basis for current CVD risk assessment and prevention (5), such data are much less robust in the CKD population. Because the strong association of CKD with CVD is explained only in part by traditional CVD risk factors (6), it is hypothesized that other metabolic or inflammatory features of renal disease contribute to CVD in this population. Insulin resistance has been independently linked with CVD in both nondiabetic and type 2 diabetic subjects (7) and commonly clusters with other CVD risk factors to carry a particularly potent CVD risk (8). Insulin resistance is highly prevalent in CKD patients (9, 10) and is plausibly a risk factor for both CVD and for CKD progression (11) . However, the longitudinal associations of insulin resistance with other metabolic syndrome features and with clinical outcomes are largely unknown in this population.
Dynamic tests, such as the hyperinsulinemic-euglycemic clamp and the frequently sampled intravenous glucose tolerance test (FSIVGTT), are considered the gold standard for insulin sensitivity estimation (SI-clamp and SI-FSIVGTT, respectively) but are impractical in a largestudy setting (12, 13) . Insulin resistance usually is estimated in epidemiologic studies by fasting insulin concentration (I 0 ) or by steady-state insulin sensitivity (SI-SS) indices derived from the relationship between I 0 and fasting glucose (G 0 ) values (14, 15) . SI-SS indices, such as those based on the homeostasis model assessment (HOMA), have been found to be appropriate surrogate variables for SI-clamp or SI-FSIVGTT across a broad spectrum of insulin sensitivity and glucose tolerance (16 -18) and are considered suitable for use in epidemiologic studies by the American Diabetes Association (19) .
The validity of SI-SS indices has, however, not been established in the CKD population. The kidney plays an important role in insulin metabolism (20) , and the mechanisms underlying insulin resistance in CKD may differ from those in patients with normal kidney function (21) . Further, SI-SS indices are not effective surrogates for dynamic test-derived insulin sensitivity estimates in all populations (22, 23) . Therefore, we hypothesized that SI-SS indices might not provide effective estimation of insulin sensitivity in patients with CKD, particularly in those with advanced renal failure. To evaluate this hypothesis, we assessed the correlation between SI-SS indices and SI-FSIVGTT in nondiabetic subjects across a broad spectrum of CKD. Many of these subjects also are participants in the National Institutes of Health-sponsored Chronic Renal Insufficiency Cohort study, an ongoing prospective cohort study of 3,000 CKD patients to identify determinants of CVD and CKD progression in this population (24) . The ultimate goal of our study was to establish the validity of SI-SS indices for future use in the Chronic Renal Insufficiency Cohort study and other epidemiologic studies of patients with CKD.
RESEARCH DESIGN AND METHODS -Eligible subjects were aged 18 -75 years and 1) had an estimated glomerular filtration rate (eGFR) Ͻ75 ml/min per 1.73 m 2 by the four-variable Modification of Diet in Renal Disease estimating equation using a single serum creatinine value standardized to the Cleveland Clinic Foundation laboratory or 2) received maintenance hemodialysis for end-stage renal disease. Exclusion criteria included pregnancy, known diabetes or fasting blood glucose Ͼ125 mg/dl at screening, corticosteroid use within the past 6 months, or a terminal diagnosis. Subjects were recruited by advertisement and by investigator-initiated query at primary care clinics, nephrology clinics, and maintenance hemodialysis facilities at or affiliated with the hospital of the University of Pennsylvania or the Philadelphia Veterans Administration Medical Center. Written informed consent was obtained from each subject in compliance with institutional review boards at these institutions.
The study procedure took place during a single admission to the General Clinical Research Center at the hospital of the University of Pennsylvania. After an overnight fast, subjects underwent a 3-h FSIVGTT, as previously described (25) , with the dose of insulin administered modified to be 0.01, 0.02, or 0.03 units/kg (based on eGFR Ͻ30, 30 -Ͻ60, or Ͼ60 ml/min per 1.73m 2 , respectively).
Analytical procedures and data analysis Demographic variables and body weight and height were collected. Plasma immunoreactive insulin was measured in duplicate by double-antibody radioimmunoassay (Linco Research, St. Louis, MO). Plasma glucose was measured by automated glucose meter (YSI, Yellow Springs, OH) at bedside during the FSIVGTT. SI-FSIVGTT was derived using MINMOD Millennium (version 6.02) software (26) . Letting I 0 and G 0 equal the mean of four fasting plasma insulin and glucose values measured at time Ϫ15, Ϫ10, Ϫ5, and Ϫ1 min (immediately before the FSIVGTT), the following SI-SS indices were derived: HOMA of insulin resistance (IR-HOMA) ϭ [I 0 (U/ml) ϫ G 0 (mmol/ l)]/22.5, log(IR-HOMA), SI-HOMA ϭ 1/(IR-HOMA), and QUICKI (quantitative insulin sensitivity check index) ϭ 1/[log (I 0 ) ϩ log (G 0 )]. I 0 , log(I 0 ), and 1/I 0 also were considered. SI-SS values based only on single insulin and glucose measurements, obtained at the Ϫ1 min time point, also were examined. Glucose values were converted to millimoles per liter (mmol/l) for SI-SS calculations.
Statistical methods
Standard descriptive statistics were used. The assumption of normal distribution across the independent variables was examined. Treating SI-FSIVGTT as the dependent variable, univariable linear regression models for each SI-SS index were fit. Pearson correlation coefficients (r) were tested using one-sample t tests against a null hypothesis that the population correlation coefficient () ϭ 0. Interactions between these correlations and potential covariables including eGFR, age, race (black versus nonblack), sex, and BMI were explored as discussed in RESULTS. In supplemental analyses, Spearman's rank correlations (r s ) also were obtained. A two-tailed P value Ͻ0.05 was the criterion for statistical significance. Analyses were performed using STATA 9.0. Table 1 Steady-state insulin sensitivity indices in CKD (2.8 -48.7) and 77 mg/dl (57-129), respectively. Between-subject variability, expressed as coefficient of variation (CV) ([SD divided by the mean] ϫ 100), was much larger for insulin (71%) than for glucose (19%). There was moderate within-subject variability in fasting insulin levels, consistent with assay characteristics and known fluctuations in plasma insulin levels over short periods of time (27) . The median (range) intrasubject CV for fasting insulin levels was 10% (4 -40), and three of the 27 subjects had a CV Ͼ20% (22, 24, and 40%). By contrast, the median (range) intrasubject CV for fasting glucose levels was 3% (0.5-9).
RESULTS -

Correlations between SI-FSIVGTT and SI-SS indices
The two-way distributions of SI-FSIVGTT and six of the SI-SS indices are provided graphically in Fig. 1 , and Pearson correlation coefficients are listed in Table 2 . All correlations were statistically significant. For indices obtained using the mean of four fasting insulin and glucose values over 15 min, Pearson correlation coefficients (|r|) ranged from 0.51 to 0.87 (P Ͻ 0.01 for each). For indices using single fasting insulin and glucose values, |r| ranged from 0.51 to 0.72 (P Ͻ 0.01 for each). Indices using log or reciprocal transformations to limit the impact of outlying data [log(IR-HOMA), SI-HOMA, quantitative insulin sensitivity check index, log(I 0 ), and 1/I 0 ] were more highly correlated with SI-FSIVGTT than indices using untransformed data (IR-HOMA and I 0 ). In general, indices based on I 0 alone were at least as highly correlated with SI-FSIVGTT as indices derived from both I 0 and G 0 data. By both the four and one time point approaches, 1/I 0 had the highest (or nearly highest) correlation with SI-FSIVGTT (r ϭ 0.87 and 0.71, respectively). Use of one time point rather than four to derive I 0 and G 0 substantially attenuated the correlations with SI-FSIVGTT for 
-Correlation between SI-FSIVGTT and SI-SS parameters in CKD. The SI-FSIVGTT and SI-SS parameters (A-F) are correlated. Data are presented as x-y scatter plots with best-fit regression line along with the strength (r) and significance (P) of correlation derived from Pearson's correlation analysis.
indices using reciprocal transformations (SI-HOMA, quantitative insulin sensitivity check index, and 1/I 0 ) but had more modest impact on the correlations with SI-FSIVGTT for the other indices. This finding was principally explained by one subject whose fasting plasma insulin levels were highly variable (CV 40% for the four fasting insulin values). After exclusion of this subject, Pearson correlation coefficients with SI-FSIVGTT for all SI-SS indices derived from single time point values differed by Ͻ2% from the corresponding correlation coefficients based on four time point values. Because SI-FSIVGTT was not normally distributed, Spearman's rank correlations (r s ) also were obtained. |r s | ϭ Ն0.77 (P Ͻ 0.0001) for all indices assessed by both the four and one time point approaches.
Findings among subjects stratified according to eGFR level were comparable with those combining subjects across eGFR levels. For indices based on the mean of four fasting time points, the logor reciprocal-transformed indices were most highly correlated with SI-FSIVGTT at both higher and lower eGFR levels, whereas for indices based on a single fasting time points the log-transformed indices were most highly correlated with SI-FSIVGTT. By the four-time point approach, Pearson correlation coefficients (|r|) with SI-FSIVGTT among 13 subjects with eGFR Ͻ48 ml/min per 1.73m 2 (the median eGFR value) were 0.47 (P ϭ 0.11) for IR-HOMA, 0.63 (P ϭ 0.02) for log IR-HOMA, 0.49 (P ϭ 0.09) for I 0 , and ranged from 0.69 to 0.86 (all P Ͻ 0.01) for the other four SI-SS indices. Among 14 subjects with eGFR Ն48 ml/ min per 1.73m 2 , the Pearson correlation coefficient (|r|) was 0.63 (P ϭ 0.02) for IR-HOMA and 0.85-0.89 (all P Ͻ 0.01) for the other six indices. In keeping with these findings, tests for whether the association of each SI-SS with SI-FSIVGTT changed according to eGFR level Ͻ or Ն48 ml/min per 1.73m 2 were not significant (P values 0.32-0.97). In additional analyses, the Pearson correlation coefficients (|r|) were 0.73-0.96 for eGFR 60 -70 ml/min per 1.73m 2 (CKD stage 2; n ϭ 4), 0.53 (IR-HOMA; P ϭ 0.02) to 0.89 (1/I 0 ; P Ͻ 0.0001) for eGFR 15 to Ͻ60 ml/min per 1.73m 2 (CKD stages 3-4; n ϭ 19), and 0.31-0.45 for eGFR Ͻ15 ml/min per 1.73m 2 (CKD stage 5; n ϭ 4). The precision of the estimates and the significance levels for CKD stages 2 and 5 were limited due to the small sample size in these categories.
Each SI-SS index retained statistically significant association with SI-FSIVGTT in multivariable linear regression models (P Ͻ 0.01 for each SI-SS index, in separate models). In the same models, age, BMI, and eGFR level were not significantly associated with SI-FSIVGTT, whereas black race was associated with greater insulin resistance by SI-FSIVGTT than nonblack race (all P Յ 0.05). In a series of exploratory analyses, correlations between SI-FSIVGTT and each SI-SS index also did not vary significantly when stratified by age, race, sex, or BMI.
␤-Cell function and fasting glucose in CKD Significant inverse correlations were found between G 0 and FSIVGTT-derived parameters of pancreatic ␤-cell function including both the disposition index (AIR gluc ϫ SI) and the acute insulin response to glucose (AIR gluc ) as follows ( Fig. 2) : disposition index (r ϭ Ϫ0.59, P ϭ 0.001), AIR gluc (r ϭ Ϫ0.49, P ϭ 0.009). Conversely, no correlation was seen between G 0 and SI-FSIVGTT (r ϭ 0.02, P ϭ 0.93).
CONCLUSIONS -This study demonstrates, in subjects with CKD, a strong and significant correlation between insulin sensitivity estimates derived from fasting glucose and insulin data and the MINMOD-derived parameter of SI- FSIVGTT. Validity of these indices has been demonstrated in the general population (14, 15) and in some (28, 29) , but not all (23), select populations. A single study has validated the use of SI-SS indices in renal transplant recipients (30) , but the relevance of that study to the nontransplant CKD population is limited by important factors. These include the impact of immune-suppressive agents on glucose metabolism (31) and the excellent graft function of its subjects, which impairs its relevance to the setting of advanced renal insufficiency. In contrast, 23 of 27 subjects in the current study had K/DOQI stages 3-5 (glomerular filtration rate Ͻ60 ml/min per 1.73m 2 ) CKD (32). An additional study did correlate IR-HOMA with SI-clamp in a population that contained a minority of subjects with elevated serum creatinine (17 of 113 ϭ 15%) but did not report correlation specifically in this group with renal insufficiency (33) . Therefore, the current study provides the first specific validation of SI-SS indices across a wide spectrum of CKD in nontransplant subjects.
The sample size of this study was relatively small, and replication of these results at other centers will strengthen these conclusions. However, the overall correlations demonstrated here between SI-SS indices and SI-FSIVGTT are statistically significant and similar in strength to those seen in multiple studies across diverse populations (16,28 -30) . Our results specifically support the utility of the SI-SS indices in stage 3 CKD, a critical group because of both its large size (3) and the substantial associated risk of CVD (4). This suggests that CKD does not disrupt the correlation between hepatic insulin sensitivity, which the SI-SS indices principally reflect, and insulin sensitivity at peripheral tissues including skeletal muscle and adipose, which contribute substantially to insulin sensitivity estimated with dynamic methods such as the FSIVGTT (16, 34) . The small number of subjects with stage 5 CKD precludes any conclusion specifically pertaining to this group.
Our data indicate that valid insulin sensitivity estimates can be effectively derived from single fasting insulin and glucose measurements in nondiabetic CKD subjects. This is in agreement with data from a diabetic population (15) and greatly enhances the feasibility of using SI-SS indices in large CKD studies. Further, and as seen in other studies (29, 30, 35) , parameters derived from both insulin and glucose values were not superior to either raw fasting insulin values or transformations of fasting insulin (logI 0 , 1/I 0 ). Fasting glucose concentration may contribute relatively little information regarding insulin sensitivity in nondiabetic populations, as it is maintained in a relatively restricted range, whereas fasting insulin concentrations vary widely according to insulin sensitivity (35) . This was reflected in the current study by the much larger between-subject CV for insulin than for glucose. Finally, SI-SS indices using logarithmic or inverse transformations were uniformly more highly correlated with SI-FSIVGTT than untransformed SI-SS indices (IR-HOMA and I 0 ), suggesting that data transformation should be utilized. Overall, our findings indicate that measurement of a single fasting insulin value will permit effective insulin sensitivity estimation in nondiabetic CKD subjects.
As fasting blood glucose did correlate significantly with FSIVGTT-derived parameters of ␤-cell function but did not correlate with SI-FSIVGTT, it is likely that ␤-cell function plays a much more important role than insulin sensitivity in determining fasting blood glucose concentrations in this nondiabetic CKD population. This inverse correlation between fasting blood glucose and ␤-cell function has been observed in subjects with normal glucose tolerance and impaired fasting glucose (36) , as well as in pancreatic islet transplant recipients (37) . This is consistent with the postulate that insulin secretion will compensate for insulin resistance in the setting of CKD if ␤-cell function is adequate.
Insulin sensitivity estimation has been used in large-scale studies for multiple purposes. These include exploration of the association between insulin resistance and CVD (38 -42) , as well as the investigation of other potential emerging CVD risk factors (17) and the physiologic impact of genetic variations within metabolically active genes (18, 43) . Therefore, the use of these indices will significantly expand the hypotheses that may be addressed in Chronic Renal Insufficiency Cohort and other CKD population-based studies, including those exploring the relationship between insulin resistance and both CVD and the progression of renal insufficiency in this select population.
